Evidence map›Paper›PMID 19423540›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Common variation in genes related to innate immunity and risk of adult glioma.

Preetha Rajaraman, Alina V Brenner, Mary Ann Butler, Sophia S Wang, Ruth M Pfeiffer, Avima M Ruder, Martha S Linet, Meredith Yeager, Zhaoming Wang, Nick Orr and 6 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Genes · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neuroserpin: structure, function, physiology and pathology.Cellular and molecular life sciences : CMLS · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency.Cold Spring Harbor molecular case studies · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Preetha RajaramanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA. rajarama@mail.nih.gov
Alina V Brenner
Mary Ann Butler
Sophia S Wang
Ruth M Pfeiffer
Avima M Ruder
Martha S Linet
Meredith Yeager
Zhaoming Wang
Nick Orr
Howard A Fine
Deukwoo Kwon
Gilles Thomas
Nathaniel Rothman
Peter D Inskip
Stephen J Chanock

Funding

Studies of Non-Ionizing Radiation-Related CancerZIACP010135 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CAHOON, ELIZABETH · 2009 to 2025
$7.0M
STUDIES OF NON-IONIZING RADIATION-RELATED CANCERZ01CP010135 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI INSKIP, PETER D · 1997 to 2008
$2.2M
Intramural NIH HHS Z01 CP010135NCI NIH HHS N01 CO012400PHS HHS N01-C0-12400
6 · The paper itself

Abstract

Current evidence suggests that immune system alterations contribute to the etiology of adult glioma, the most common adult brain tumor. Although previous studies have focused on variation in candidate genes in the adaptive immune system, the innate immune system has emerged as a critical avenue for research given its known link with carcinogenesis. To identify genetic markers in pathways critical to innate immunity, we conducted an association study of 551 glioma cases and 865 matched controls of European ancestry to investigate "tag" single nucleotide polymorphisms (SNP) in 148 genetic regions. Two independent U.S. case-control studies included were as follows: a hospital-based study conducted by the National Cancer Institute (263 cases, 330 controls) and a community-based study conducted by the National Institute for Occupational Safety and Health (288 cases, 535 controls). Tag SNPs (1,397) chosen on the basis of an r(2) of >0.8 and minor allele frequency of >5% in Caucasians in HapMap1 were genotyped. Glioma risk was estimated by odds ratios. Nine SNPs distributed across eight genetic regions (ALOX5, IRAK3, ITGB2, NCF2, NFKB1, SELP, SOD1, and STAT1) were associated with risk of glioma with P value of <0.01. Although these associations were no longer statistically significant after controlling for multiple comparisons, the associations were notably consistent in both studies. Region-based tests were statistically significant (P < 0.05) for SELP, SOD, and ALOX5. Analyses restricted to glioblastoma (n = 254) yielded significant associations for the SELP, DEFB126/127, SERPINI1, and LY96 genetic regions. We have identified a promising set of innate immunity-related genetic regions for further investigation.

Indexed as

5-Lipoxygenase-Activating ProteinsAdolescentAdultAgedAged, 80 and overAllelesbeta-DefensinsCarrier ProteinsCase-Control StudiesCytoskeletal ProteinsEpididymal Secretory ProteinsFemaleGenetic VariationGenotypeGlioblastomaGlioma5-Lipoxygenase-Activating ProteinsALOX5AP protein, humanbeta-DefensinsCarrier ProteinsCytoskeletal ProteinsDEFB126 protein, humanEpididymal Secretory ProteinsInterleukin-1 Receptor-Associated KinasesIRAK3 protein, humanITGB1BP2 protein, humanLY96 protein, humanLymphocyte Antigen 96Membrane ProteinsMuscle ProteinsNADPH OxidasesNCF2 protein, humanNeuropeptidesNeuroserpinNF-kappa B p50 SubunitNFKB1 protein, humanSelenoprotein PSerpinsSOD1 protein, humanSTAT1 protein, humanSTAT1 Transcription FactorSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID19423540
PMCPMC2771723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.